Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
Background: Patients who develop oligorecurrent disease may be treated with metastasis-directed stereotactic body radiotherapy (SBRT) to defer the start of systemic therapy and delay its potential side effects. We report oncological outcomes and patterns of failure in patients with oligorecurrent di...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2022-11-01
|
| Series: | Clinical and Translational Radiation Oncology |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2405630822000702 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|